Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06036251 · ClinicalTrials.gov registry record
COVID-19 Pandemic Induced Stress and Symptoms
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 415
- Enrollment target
NCT06036251 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 415 participants.
The verdict
NCT06036251 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 415 participants
- Enrollment target
Study Summary
The previous survey of oncology patients at University of California, San Francisco in 2020-2021 found an alarmingly high symptom burden and high levels of stress and loneliness among respondents. This is a follow-up study with the same sample of oncology patients and survivors who participated in the previous study
Interventions
- OTHER Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 415 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2023-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06036251
The ClinicalTrials.gov registry entry for NCT06036251 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 415 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires is the first listed.
NCT06036251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06036251 about?
NCT06036251 is a clinical study titled "COVID-19 Pandemic Induced Stress and Symptoms". The previous survey of oncology patients at University of California, San Francisco in 2020-2021 found an alarmingly high symptom burden and high levels of stress and loneliness among respondents. This is a follow-up study with the same sample of oncology patients and survivors who participated in t...
What is the current status of trial NCT06036251?
This trial is currently completed. The enrollment target is 415 participants. The study started on 2023-02-01. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT06036251?
The interventions under investigation include: Questionnaires (OTHER).
Who is sponsoring clinical trial NCT06036251?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.